Market Size of North America Diabetes Care Devices Industry
Study Period | 2019- 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 27.52 Billion |
Market Size (2029) | USD 37.19 Billion |
CAGR (2024 - 2029) | 6.21 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
North America Diabetes Care Devices Market Analysis
The North America Diabetes Care Devices Market size is estimated at USD 27.52 billion in 2024, and is expected to reach USD 37.19 billion by 2029, growing at a CAGR of 6.21% during the forecast period (2024-2029).
The PAHO Panorama of Diabetes report highlights the alarming increase in diabetes cases in the Americas. The projected number of individuals affected by diabetes is expected to rise from 62 million in 2022 to 109 million by 2040 if current patterns persist. This emphasizes the urgent need for increased awareness, prevention, and management strategies to address this growing public health challenge. Further, the report emphasizes the importance of early detection and diagnosis, as many individuals may be living with diabetes without even realizing it. This lack of awareness can delay necessary treatment and increase the risk of complications. Therefore, efforts to improve screening and testing for diabetes are crucial to identify and support those who are affected.
The North American region has witnessed an astounding increase in the prevalence of diabetes, in recent years. In developed countries, such as the United States and Canada, the rate of diabetes is at an all-time high, mainly due to lifestyle changes. Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and thus incur more healthcare expenses compared to non-diabetic people.
Patients with Type 2 diabetes require many corrections throughout the day to maintain nominal blood glucose levels, such as the administration of additional insulin or ingestion of additional carbohydrates. Furthermore, patients attempting to control their blood glucose levels tightly to prevent the long-term complications associated with fluctuations in blood glucose levels are at greater risk for overcorrection and the resultant hypoglycemia. Achieving nominal results can be very difficult without multiple daily injections of insulin or insulin pump therapy. This is driving the demand for diabetes care devices in North America, thereby driving the market in focus during the forecast period.
North America Diabetes Care Devices Industry Segmentation
Diabetes patients can monitor and control their blood glucose levels with the use of diabetes equipment. Using diabetes devices can dramatically improve your diabetes status. The North American diabetes care devices market is segmented by monitoring devices, management devices, and geography. The report offers the value (in USD) and Volume (in Units) for the above segments.
Product | |||||||||||
| |||||||||||
|
Geography | |
United States | |
Canada | |
Rest of North America |
North America Diabetes Care Devices Market Size Summary
The North America Diabetes Care Devices Market is poised for significant growth, driven by the increasing prevalence of diabetes in the region. The market is experiencing a surge in demand for diabetes care devices due to lifestyle changes and the rising incidence of diabetes-related complications. This has led to a heightened focus on early detection, diagnosis, and management strategies to combat the growing public health challenge. The adoption of monitoring devices, such as continuous glucose monitors (CGMs) and blood glucose meters, is on the rise, supported by favorable reimbursement options and technological advancements. These devices empower patients to make informed health decisions, thereby enhancing their quality of life and reducing healthcare costs associated with diabetes complications.
The market landscape is characterized by innovation and strategic developments, with key players like Abbott, Dexcom, and Medtronic leading the charge in advancing diabetes care technologies. The introduction of novel insulin pump devices and continuous glucose monitoring systems, along with the development of non-insulin medications, is reshaping the treatment options available to diabetic patients. The United States, in particular, is expected to witness substantial growth due to its high obesity rates and increasing awareness of diabetes care. As the market continues to evolve, the focus remains on improving patient outcomes through innovative solutions and comprehensive care strategies, ensuring a robust growth trajectory over the forecast period.
North America Diabetes Care Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. Market Segmentation
-
2.1 Product
-
2.1.1 Monitoring Devices
-
2.1.1.1 Self-monitoring Blood Glucose Devices
-
2.1.1.1.1 Glucometer Devices
-
2.1.1.1.2 Blood Glucose Test Strips
-
2.1.1.1.3 Lancets
-
-
2.1.1.2 Continuous Glucose Monitoring
-
2.1.1.2.1 Sensors
-
2.1.1.2.2 Durables
-
-
-
2.1.2 Management Devices
-
2.1.2.1 Insulin Pump
-
2.1.2.1.1 Insulin Pump Device
-
2.1.2.1.2 Insulin Pump Reservoir
-
2.1.2.1.3 Infusion Set
-
-
2.1.2.2 Insulin Syringes
-
2.1.2.3 Cartridges in Reusable pens
-
2.1.2.4 Insulin Disposable Pens
-
2.1.2.5 Jet Injectors
-
-
-
2.2 Geography
-
2.2.1 United States
-
2.2.2 Canada
-
2.2.3 Rest of North America
-
-
North America Diabetes Care Devices Market Size FAQs
How big is the North America Diabetes Care Devices Market?
The North America Diabetes Care Devices Market size is expected to reach USD 27.52 billion in 2024 and grow at a CAGR of 6.21% to reach USD 37.19 billion by 2029.
What is the current North America Diabetes Care Devices Market size?
In 2024, the North America Diabetes Care Devices Market size is expected to reach USD 27.52 billion.